XML 51 R39.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2017
Segment Reporting [Abstract]  
Summary Of Segment Performance



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

For the Three Months Ended March 31,

 



 

 

CAG

 

Water

 

LPD

 

Other

 

Unallocated Amounts

 

Consolidated Total

 

2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

403,227 

 

$

25,077 

 

$

29,317 

 

$

4,400 

 

$

 -

 

$

462,021 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

$

79,855 

 

$

10,263 

 

$

3,802 

 

$

393 

 

$

(2,070)

 

$

92,243 

 

Interest expense, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(7,506)

 

Income before provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

84,737 

 

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,679 

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

69,058 

 

Less: Net income attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

39 

 

Net income attributable to IDEXX Laboratories, Inc. stockholders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

69,019 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

357,639 

 

$

23,552 

 

$

30,856 

 

$

5,503 

 

$

 -

 

$

417,550 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

$

61,378 

 

$

9,679 

 

$

4,570 

 

$

(837)

 

$

(997)

 

$

73,793 

 

Interest expense, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(7,484)

 

Income before provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

66,309 

 

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20,284 

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

46,025 

 

Less: Net income attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to IDEXX  Laboratories, Inc. stockholders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

46,019 

 



Summary Of Revenue By Product And Service Category



 

 

 

 

 

 

 



 

For the Three Months Ended

 



 

March 31,

 



 

 

2017 

 

 

2016 

 

CAG segment revenue:

 

 

 

 

 

 

 

CAG Diagnostics recurring revenue:

 

$

346,680 

 

$

305,841 

 

IDEXX VetLab consumables

 

 

123,553 

 

 

107,969 

 

Rapid assay products

 

 

47,895 

 

 

43,086 

 

Reference laboratory diagnostic and consulting services

 

 

159,069 

 

 

140,708 

 

CAG Diagnostics service and accessories

 

 

16,163 

 

 

14,078 

 

CAG Diagnostics capital - instruments

 

 

26,183 

 

 

22,643 

 

Veterinary software, services and diagnostic imaging systems

 

 

30,364 

 

 

29,155 

 

CAG segment revenue

 

 

403,227 

 

 

357,639 

 



 

 

 

 

 

 

 

Water segment revenue

 

 

25,077 

 

 

23,552 

 

LPD segment revenue

 

 

29,317 

 

 

30,856 

 

Other segment revenue

 

 

4,400 

 

 

5,503 

 

Total revenue

 

$

462,021 

 

$

417,550